Nutex Health (NASDAQ:NUTX) Shares Up 1.1% – Here’s Why

Nutex Health Inc. (NASDAQ:NUTX) traded up 1.1% during mid-day trading on Thursday . The stock traded as high as $151.00 and last traded at $149.10. 77,009 shares changed hands during trading, a decline of 37% from the average session volume of 122,047 shares. The stock had previously closed at $147.54.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on NUTX shares. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Lake Street Capital began coverage on Nutex Health in a report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target for the company. B. Riley Financial began coverage on Nutex Health in a research report on Friday. They set a “buy” rating and a $290.00 price objective on the stock. Finally, Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $243.33.

Nutex Health Stock Up 11.6%

The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The company has a market capitalization of $1.14 billion, a price-to-earnings ratio of 12.86 and a beta of 0.26. The business has a 50 day simple moving average of $129.24 and a 200 day simple moving average of $130.34.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, beating the consensus estimate of $3.99 by $2.53. The company had revenue of $216.49 million during the quarter, compared to the consensus estimate of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.

Institutional Trading of Nutex Health

A number of large investors have recently made changes to their positions in the company. Pertento Partners LLP acquired a new stake in shares of Nutex Health in the 3rd quarter valued at $27,940,000. Topline Capital Management LLC raised its holdings in Nutex Health by 80.0% during the third quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after purchasing an additional 247,436 shares in the last quarter. Millennium Management LLC grew its position in shares of Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after buying an additional 61,308 shares during the last quarter. Empowered Funds LLC acquired a new position in Nutex Health in the first quarter valued at $3,084,000. Finally, SG Americas Securities LLC lifted its holdings in shares of Nutex Health by 3,232.6% in the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after purchasing an additional 29,449 shares during the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.